Division of Hematology, Department of Internal Medicine, The Ohio State University , Columbus, OH , USA .
Amyloid. 2014 Jun;21(2):110-2. doi: 10.3109/13506129.2014.891502. Epub 2014 Mar 6.
Familial Amyloidosis of Finnish type (FAF) is a rare type of autosomal dominant hereditary amyloidosis associated with genetic variants of gelsolin. Three amyloidogenic mutations have previously been reported characteristically presenting with ophthalmologic abnormalities, progressive cranial neuropathy and cutis laxa. We report a novel gelsolin variant in a 62-year-old man with nephrotic range proteinuria of 13.2 grams/day as the only presenting symptom. Renal biopsy followed by laser micro-dissection and mass spectrometry showed amyloidosis derived from gelsolin. DNA sequencing revealed the novel gelsolin mutation (c.633C > A) encoding p.N211K protein variant. Four of 13 asymptomatic family members were found to be heterozygous for the p.N211K mutation, three of whom had proteinuria of varying degree including one who proceeded to renal biopsy and was confirmed to have renal amyloidosis. Follow-up of these cases might give us more insight into pathogenicity and potential treatment strategy of this atypical presentation of gelsolin amyloidosis.
芬兰型家族性淀粉样变性(FAF)是一种罕见的常染色体显性遗传性淀粉样变性,与凝溶胶蛋白的遗传变异有关。以前已经报道了三种淀粉样变性突变,其特征表现为眼科异常、进行性颅神经病和皮肤松弛症。我们报告了一例 62 岁男性的新型凝溶胶变异,其唯一表现为肾病范围蛋白尿(13.2 克/天)。肾脏活检后行激光微切割和质谱分析显示淀粉样变性来自凝溶胶蛋白。DNA 测序显示新型凝溶胶突变(c.633C>A),编码 p.N211K 蛋白变异体。在 13 名无症状的家族成员中,有 4 人被发现为 p.N211K 突变的杂合子,其中 3 人有不同程度的蛋白尿,包括 1 人进行了肾脏活检并被证实患有肾脏淀粉样变性。对这些病例的随访可能会让我们更深入地了解这种凝溶胶淀粉样变性的不典型表现的致病机制和潜在治疗策略。